CN113693131A - 一种益生菌富硒高钙中老年配方奶粉 - Google Patents
一种益生菌富硒高钙中老年配方奶粉 Download PDFInfo
- Publication number
- CN113693131A CN113693131A CN202110954228.4A CN202110954228A CN113693131A CN 113693131 A CN113693131 A CN 113693131A CN 202110954228 A CN202110954228 A CN 202110954228A CN 113693131 A CN113693131 A CN 113693131A
- Authority
- CN
- China
- Prior art keywords
- parts
- linoleic acid
- conjugated linoleic
- trans
- cis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 65
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 58
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 38
- 239000011669 selenium Substances 0.000 title claims abstract description 38
- 239000006041 probiotic Substances 0.000 title claims abstract description 33
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 33
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 33
- 239000011575 calcium Substances 0.000 title claims abstract description 30
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 30
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 105
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims abstract description 93
- 229940108924 conjugated linoleic acid Drugs 0.000 claims abstract description 88
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 26
- 239000011707 mineral Substances 0.000 claims abstract description 26
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 23
- 235000013336 milk Nutrition 0.000 claims abstract description 16
- 239000008267 milk Substances 0.000 claims abstract description 16
- 210000004080 milk Anatomy 0.000 claims abstract description 16
- 229930091371 Fructose Natural products 0.000 claims abstract description 14
- 239000005715 Fructose Substances 0.000 claims abstract description 14
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 12
- 235000020185 raw untreated milk Nutrition 0.000 claims abstract description 12
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 12
- 239000008158 vegetable oil Substances 0.000 claims abstract description 12
- 229940088594 vitamin Drugs 0.000 claims abstract description 12
- 229930003231 vitamin Natural products 0.000 claims abstract description 12
- 235000013343 vitamin Nutrition 0.000 claims abstract description 12
- 239000011782 vitamin Substances 0.000 claims abstract description 12
- 102000008186 Collagen Human genes 0.000 claims abstract description 11
- 108010035532 Collagen Proteins 0.000 claims abstract description 11
- 229920001436 collagen Polymers 0.000 claims abstract description 11
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 9
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims abstract description 9
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 9
- 241000283690 Bos taurus Species 0.000 claims abstract description 9
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims abstract description 9
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 9
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 9
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 9
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 9
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 9
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 9
- -1 phytosterol ester Chemical class 0.000 claims abstract description 9
- 229940075999 phytosterol ester Drugs 0.000 claims abstract description 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 9
- 239000005862 Whey Substances 0.000 claims abstract description 6
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 6
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 6
- 235000012907 honey Nutrition 0.000 claims abstract description 6
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 6
- 235000010755 mineral Nutrition 0.000 claims description 23
- IOCYQQQCJYMWDT-UHFFFAOYSA-N (3-ethyl-2-methoxyquinolin-6-yl)-(4-methoxycyclohexyl)methanone Chemical compound C=1C=C2N=C(OC)C(CC)=CC2=CC=1C(=O)C1CCC(OC)CC1 IOCYQQQCJYMWDT-UHFFFAOYSA-N 0.000 claims description 20
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 18
- 239000008101 lactose Substances 0.000 claims description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 14
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 14
- 235000012424 soybean oil Nutrition 0.000 claims description 10
- 239000003549 soybean oil Substances 0.000 claims description 10
- 241001608472 Bifidobacterium longum Species 0.000 claims description 7
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 7
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 7
- 239000002211 L-ascorbic acid Substances 0.000 claims description 7
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 7
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 7
- 229960005070 ascorbic acid Drugs 0.000 claims description 7
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 7
- 239000011790 ferrous sulphate Substances 0.000 claims description 7
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 7
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 7
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 7
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 7
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 7
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 7
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 7
- 229960000342 retinol acetate Drugs 0.000 claims description 7
- 235000019173 retinyl acetate Nutrition 0.000 claims description 7
- 239000011770 retinyl acetate Substances 0.000 claims description 7
- 229960003080 taurine Drugs 0.000 claims description 7
- 235000005282 vitamin D3 Nutrition 0.000 claims description 7
- 239000011647 vitamin D3 Substances 0.000 claims description 7
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- 229940021056 vitamin d3 Drugs 0.000 claims description 7
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 7
- 229960001763 zinc sulfate Drugs 0.000 claims description 7
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 6
- 229920001202 Inulin Polymers 0.000 claims description 6
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 6
- 229940029339 inulin Drugs 0.000 claims description 6
- GKJZMAHZJGSBKD-NMMTYZSQSA-N (10E,12Z)-octadecadienoic acid Chemical compound CCCCC\C=C/C=C/CCCCCCCCC(O)=O GKJZMAHZJGSBKD-NMMTYZSQSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 239000000905 isomalt Substances 0.000 claims description 5
- 235000010439 isomalt Nutrition 0.000 claims description 5
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 5
- 229960001375 lactose Drugs 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229940042585 tocopherol acetate Drugs 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 4
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 2
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 2
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 claims description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims 1
- 229960001781 ferrous sulfate Drugs 0.000 claims 1
- SERLAGPUMNYUCK-YJOKQAJESA-N 6-O-alpha-D-glucopyranosyl-D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-YJOKQAJESA-N 0.000 abstract description 12
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 235000013365 dairy product Nutrition 0.000 abstract description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract 3
- 230000035764 nutrition Effects 0.000 abstract 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 12
- 235000020778 linoleic acid Nutrition 0.000 description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 10
- 241000186000 Bifidobacterium Species 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 208000026106 cerebrovascular disease Diseases 0.000 description 5
- 102000036675 Myoglobin Human genes 0.000 description 4
- 108010062374 Myoglobin Proteins 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 235000021243 milk fat Nutrition 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 201000010538 Lactose Intolerance Diseases 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical compound [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003871 intestinal function Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种益生菌富硒高钙中老年配方奶粉，属于乳制品加工领域。原料组成为生牛乳干物质、脱脂乳粉、脱盐乳清粉、异麦芽酮糖醇、膳食纤维、结晶果糖、植物油、牛骨胶原蛋白肽、乳矿物盐、植物甾醇酯、复配维生素、复配矿物质、酵母β‑葡聚糖、蜂蜜粉、磷脂酰丝氨酸、富硒酵母、乳铁蛋白、益生菌组合。本发明奶粉针对中老年人群的健康状况和营养需求可提供更全面科学的营养，添加了异麦芽酮糖醇、牛骨胶原蛋白肽、乳矿物盐、植物甾醇酯、酵母β‑葡聚糖、乳铁蛋白、磷酯酰丝氨酸、共轭亚油酸等功能成分，更适合糖尿病、高血压的中老年人群和肥胖人群食用。
Description
技术领域
本申请涉及乳制品加工领域，尤其涉及一种益生菌富硒高钙中老年配方奶粉。
背景技术
近年来，中老年人群的健康状况越来越受到关注，中老年人群的高血脂、高血压、高血糖症状比较普遍，心脑血管疾病的发病率比较高，当前市售的中华老年配方奶粉都是单一的营养补充品，营养成分不能很好地适应中老年人群的营养需求。因此，设计一款真正适合中老年人群的健康状况和营养需求的配方奶粉显得尤为重要，急需设计一种适合糖尿病人群和高血压人群食用的配方奶粉。
发明内容
本申请提供了一种益生菌富硒高钙中老年配方奶粉，以期解决或部分解决背景技术中涉及的上述问题。
本申请提出了这样一种益生菌富硒高钙中老年配方奶粉，包括包括如下质量份数比的成分：生牛乳干物质20.6～22.6份；脱脂乳粉29.2～30.8份；脱盐乳清粉19.2～20.8份；异麦芽酮糖醇10.0～11.0份；膳食纤维5.7～6.7份；结晶果糖占4.8～5.2份；植物油3.2～3.8份；牛骨胶原蛋白肽0.9～1.1份；乳矿物盐0.75～0.85份；植物甾醇酯0.37～0.43份；复配维生素0.245～0.255份；复配矿物质0.18～0.22份；酵母β-葡聚糖0.09～0.11份；蜂蜜粉0.09～0.11份；磷脂酰丝氨酸0.045～0.055份；富硒酵母0.009～0.011份；乳铁蛋白0.009～0.011份；益生菌组合0.009～0.011份。
在一些实施方式中，膳食纤维包括以下原料组份，按质量份数比：低聚麦芽糖76.4～77.4份、菊粉22.6～23.6份。
在一些实施方式中，植物油包括以下原料组份，按质量份数比：大豆油93.8～94.8份、共轭亚油酸5.2～6.2份。其中，共轭亚油酸包括但不限于顺-9，反-11-共轭亚油酸或反-9，顺-11-共轭亚油酸或反-9，反-11-共轭亚油酸或顺-9，顺-11-共轭亚油酸或反-10，顺-12-共轭亚油酸或顺-10，反-12-共轭亚油酸或顺-10，顺-12-共轭亚油酸或反-10，反-12-共轭亚油酸或顺-8，反-10-共轭亚油酸或反-8，顺-10-共轭亚油酸或顺-8，顺-10-共轭亚油酸或反-8，反-10-共轭亚油酸或反-11，顺-13-共轭亚油酸或顺-11，反-13-共轭亚油酸或顺-11，顺-13-共轭亚油酸或反-11，反-13-共轭亚油酸。
在一些实施方式中，复配维生素包括维生素A醋酸视黄酯、胆钙化醇、dl-α-醋酸生育酚、盐酸吡哆醇、L-抗坏血酸、牛磺酸和乳糖。
进一步地，复配维生素中的各组分的质量份数比为：维生素A醋酸视黄酯2.660～2.668份；胆钙化醇1.730～1.746份；dl-α-醋酸生育酚23.50～24.32份；盐酸吡哆醇0.0575～0.0590份；L-抗坏血酸36.60～36.84份；牛磺酸18.00～18.80份；乳糖15.90～16.10份。
在一些实施方式中，复配矿物质包括硫酸亚铁、硫酸锌和乳糖。
进一步地，复配矿物质中的各组分的质量份数比为：硫酸亚铁24.5～25.5份，硫酸锌7.90～8.90份，乳糖66.1～67.1份。
在一些实施方式中，益生菌组合包括如下组分，按质量份数比：动物双歧杆菌BB-115 32.8～33.8份、鼠李糖乳杆菌MP108 32.8～33.8份、长双歧杆菌婴儿亚种BLI-02 32.8～33.8份。
根据上述的实施方式的技术方案可至少获得以下至少一个有益效果。
本发明的配方奶粉是通过对市售中老年配方奶粉的调研，参照国家相应的食品安全国家标准而设计出来的适合中老年人群食用的配方奶粉。本配方奶粉不仅可以很好地匹配中老年人群的健康需求，还可以起到保健调理的功效。
本发明的配方奶粉通过降低生牛乳的使用量来降低配方中的乳脂肪的含量。通过自检可发现乳脂肪中反式脂肪酸的含量为5.32％，本配方中生牛乳的使用量约为1800kg/吨粉，生牛乳的脂肪含量在3.5-4.0％；而大豆油和共轭亚油酸中的不含有反式脂肪酸，本配方中反式脂肪酸占总脂肪酸的比例为3.25-3.72％，总含量为0.32--0.37g/100g。
由于人体不能合成亚油酸，或是合成的量远不能满足需要的必需脂肪酸，本发明的配方奶粉通过添加大豆油来提高亚油酸的含量，本配方中亚油酸的设计含量约为2.52g/100g，其中共轭亚油酸的添加量约为0.2g/100克，占亚油酸总量的6％。亚油酸能够降低血液胆固醇、软化血管、降低血压、促进微循环，预防动脉粥样化和老年性肥胖症，减少心脑血管疾病的发病率。共轭亚油酸作为一种新食品原料，不仅具有亚油酸的全部功效，还具有很多其他功效，如增强抗氧化能力和免疫能力，增加人体的心肌肌红蛋白、骨骼肌肌红蛋白含量，增强细胞膜流动性，清除体内自由基，抗癌等。
由于中老年人群体内乳糖分解酶的含量较低，过多摄入乳糖易引起乳糖不耐症，出现腹胀、腹痛等症状。本发明的配方奶粉通过调整碳水化合物的配比，来降低乳糖的含量，本配方中强化了特殊的甜味剂结晶果糖和异麦芽酮糖醇，结晶果糖的添加比例为5.0％；异麦芽酮糖醇的添加比例为10.5％。结晶果糖甜度为蔗糖的1.8倍，可抑制人体脂肪的过量储存，抑制龋齿、促进钙的吸收。异麦芽酮糖醇甜度为蔗糖的45％～65％，不会导致龋齿，它和配方中的双歧杆菌具有协同作用，可促进双歧杆菌生长繁殖，改进中老年人群的肠道功能，维持微生态平衡。异麦芽酮糖醇和结晶果糖都不会引起体内血糖和胰岛素的升高，适合糖尿病人群和肥胖人群食用。
本发明的配方奶粉中还添加了特殊成分牛骨胶原蛋白肽。这种胶原蛋白易被人体吸收利用，可以增加皮肤弹性，防治骨质疏松和癌症，且矿物质丰富，可以调节身体内电解质平衡。
本发明的配方奶粉中选用吸收率较高的乳矿物盐作为钙质的来源，本配方中乳矿物盐的添加量约为8kg/吨粉，终产品中钙的强化量约为200mg/100g粉。乳矿物盐是天然活性高乳蛋白钙，具有科学的钙磷比2:1，易被人体吸收利用，吸收率大大高于其他普通钙，且对肠胃刺激小，不会导致肠胃不舒服，对中老年人群友好。
本发明的配方奶粉中硒的强化来源选用安琪酵母生物有限公司生产有机硒--富硒酵母，本配方中酵母硒的强化量约为20μg/100g。富硒酵母中的硒为纯生态硒，人体吸收率高，无毒副作用。
本发明的配方奶粉中添加的益生菌组合为动物双歧杆菌BB-115、鼠李糖乳杆菌MP108、长双歧杆菌婴儿亚种BLI-02，可抑制肠道内病原菌，调节肠道微生态。
本发明的配方奶粉中添加的植物甾醇酯可降低血液中胆固醇含量，预防心脑血管疾病；酵母β-葡聚糖和乳铁蛋白可增强机体免疫力，抑制肿瘤生长；磷脂酰丝氨酸可提高大脑机能，提高注意力，改善记忆力。
具体实施方式
下文提供了具体的实施方式进一步说明本发明，但本发明不仅仅限于以下的实施方式。
实施例1
本实施例提供一种益生菌富硒高钙中老年配方奶粉，按吨粉重量包含的组分及其重量克数为：生牛乳1800kg中的干物质含量206kg、脱脂乳粉292kg、脱盐乳清粉192kg、异麦芽酮糖醇100kg、膳食纤维57kg、结晶果糖48kg、植物油32kg、牛骨胶原蛋白肽9kg、乳矿物盐7.5kg、植物甾醇酯3.7kg、复配维生素2.45kg、复配矿物质1.8kg、酵母β-葡聚糖0.9kg、蜂蜜粉0.9kg、磷酯酰丝氨酸0.45kg、富硒酵母0.09kg、乳铁蛋白0.09kg、益生菌组合0.09kg。
进一步地，膳食纤维包括低聚麦芽糖43.55kg、菊粉13.45kg；植物油包括大豆油30.02kg、共轭亚油酸1.98kg；复配维生素包括维生素A醋酸视黄酯0.0652kg、胆钙化醇0.0424kg、dl-α-醋酸生育酚0.5758kg、盐酸吡哆醇0.0141kg、L-抗坏血酸0.8967kg、牛磺酸0.4606kg和乳糖0.3945kg；复配矿物质包括硫酸亚铁0.450kg、硫酸锌0.160kg和乳糖1.190kg；益生菌组合包括动物双歧杆菌BB-115 0.02952kg、鼠李糖乳杆菌MP1080.02997kg、长双歧杆菌婴儿亚种BLI-02 0.03042kg。
更进一步地，共轭亚油酸包括但不限于顺-9，反-11-共轭亚油酸或反-9，顺-11-共轭亚油酸或反-9，反-11-共轭亚油酸或顺-9，顺-11-共轭亚油酸或反-10，顺-12-共轭亚油酸或顺-10，反-12-共轭亚油酸或顺-10，顺-12-共轭亚油酸或反-10，反-12-共轭亚油酸或顺-8，反-10-共轭亚油酸或反-8，顺-10-共轭亚油酸或顺-8，顺-10-共轭亚油酸或反-8，反-10-共轭亚油酸或反-11，顺-13-共轭亚油酸或顺-11，反-13-共轭亚油酸或顺-11，顺-13-共轭亚油酸或反-11，反-13-共轭亚油酸。
实施例2
本实施例提供一种益生菌富硒高钙中老年配方奶粉，按吨粉重量包含的组分及其重量克数为：生牛乳1800kg中的干物质含量216kg、脱脂乳粉300kg、脱盐乳清粉200kg、异麦芽酮糖醇105kg、膳食纤维65kg、结晶果糖50kg、植物油35kg、牛骨胶原蛋白肽10kg、乳矿物盐8kg、植物甾醇酯4kg、复合维生素2.5kg、复合矿物质2.0kg、酵母β-葡聚糖1.0kg、蜂蜜粉1.0kg、磷酯酰丝氨酸0.5kg、富硒酵母0.1kg、乳铁蛋白0.1kg、益生菌组合0.1kg。
进一步地，膳食纤维包括低聚麦芽糖49.98kg、菊粉15.02kg；植物油包括大豆油33.0kg、共轭亚油酸2.0kg；复配维生素包括维生素A醋酸视黄酯0.0667kg、胆钙化醇0.0437kg、dl-α-醋酸生育酚0.6080kg、盐酸吡哆醇0.0147kg、L-抗坏血酸0.9210kg、牛磺酸0.4500kg和乳糖0.3975kg；复配矿物质包括硫酸亚铁0.490kg、硫酸锌0.168kg和乳糖1.342kg；益生菌组合包括动物双歧杆菌BB-115 0.0338kg、鼠李糖乳杆菌MP108 0.0328kg、长双歧杆菌婴儿亚种BLI-02 0.0333kg。
更进一步地，共轭亚油酸包括但不限于顺-9，反-11-共轭亚油酸或反-9，顺-11-共轭亚油酸或反-9，反-11-共轭亚油酸或顺-9，顺-11-共轭亚油酸或反-10，顺-12-共轭亚油酸或顺-10，反-12-共轭亚油酸或顺-10，顺-12-共轭亚油酸或反-10，反-12-共轭亚油酸或顺-8，反-10-共轭亚油酸或反-8，顺-10-共轭亚油酸或顺-8，顺-10-共轭亚油酸或反-8，反-10-共轭亚油酸或反-11，顺-13-共轭亚油酸或顺-11，反-13-共轭亚油酸或顺-11，顺-13-共轭亚油酸或反-11，反-13-共轭亚油酸。
实施例3
本实施例提供一种益生菌富硒高钙中老年配方奶粉，按吨粉重量包含的组分及其重量克数为：生牛乳1800kg中的干物质含量226kg、脱脂乳粉308kg、脱盐乳清粉208kg、异麦芽酮糖醇110kg、膳食纤维67kg、结晶果糖52kg、植物油38kg、牛骨胶原蛋白肽11kg、乳矿物盐8.5kg、植物甾醇酯4.3kg、复合维生素2.55kg、复合矿物质2.2kg、酵母β-葡聚糖1.1kg、蜂蜜粉1.1kg、磷酯酰丝氨酸0.55kg、富硒酵母0.11kg、乳铁蛋白0.11kg、益生菌组合0.11kg。
进一步地，膳食纤维包括低聚麦芽糖50kg、菊粉15kg；植物油包括大豆油33.0kg、共轭亚油酸2.0kg；复配维生素包括维生素A醋酸视黄酯0.0679kg、胆钙化醇0.0443kg、dl-α-醋酸生育酚0.6097kg、盐酸吡哆醇0.0149kg、L-抗坏血酸0.9364kg、牛磺酸0.4692kg和乳糖0.4080kg；复配矿物质包括硫酸亚铁0.561kg、硫酸锌0.174kg和乳糖1.465kg；益生菌组合包括动物双歧杆菌BB-115 0.03663kg、鼠李糖乳杆菌MP108 0.03718kg、长双歧杆菌婴儿亚种BLI-02 0.03608kg。
更进一步地，共轭亚油酸包括但不限于顺-9，反-11-共轭亚油酸或反-9，顺-11-共轭亚油酸或反-9，反-11-共轭亚油酸或顺-9，顺-11-共轭亚油酸或反-10，顺-12-共轭亚油酸或顺-10，反-12-共轭亚油酸或顺-10，顺-12-共轭亚油酸或反-10，反-12-共轭亚油酸或顺-8，反-10-共轭亚油酸或反-8，顺-10-共轭亚油酸或顺-8，顺-10-共轭亚油酸或反-8，反-10-共轭亚油酸或反-11，顺-13-共轭亚油酸或顺-11，反-13-共轭亚油酸或顺-11，顺-13-共轭亚油酸或反-11，反-13-共轭亚油酸。
本发明的配方奶粉通过降低生牛乳的使用量来降低配方中的乳脂肪的含量。通过自检可发现乳脂肪中反式脂肪酸的含量为5.32％，本配方中生牛乳的使用量约为1800kg/吨粉，生牛乳的脂肪含量在3.5-4.0％；而大豆油和共轭亚油酸中的不含有反式脂肪酸，本配方中反式脂肪酸占总脂肪酸的比例为3.25-3.72％，总含量为0.32--0.37g/100g。
由于人体不能合成亚油酸，或是合成的量远不能满足需要的必需脂肪酸，本发明的配方奶粉通过添加大豆油来提高亚油酸的含量，本配方中亚油酸的设计含量约为2.52g/100g，其中共轭亚油酸的添加量约为0.2g/100克，占亚油酸总量的6％。亚油酸能够降低血液胆固醇、软化血管、降低血压、促进微循环，预防动脉粥样化和老年性肥胖症，减少心脑血管疾病的发病率。共轭亚油酸作为一种新食品原料，不仅具有亚油酸的全部功效，还具有很多其他功效，如增强抗氧化能力和免疫能力，增加人体的心肌肌红蛋白、骨骼肌肌红蛋白含量，增强细胞膜流动性，清除体内自由基，抗癌等。
由于中老年人群体内乳糖分解酶的含量较低，过多摄入乳糖易引起乳糖不耐症，出现腹胀、腹痛等症状。本发明的配方奶粉通过调整碳水化合物的配比，来降低乳糖的含量，本配方中强化了特殊的甜味剂结晶果糖和异麦芽酮糖醇，结晶果糖的添加比例约为5.0％；异麦芽酮糖醇的添加比例约为10.5％。结晶果糖甜度为蔗糖的1.8倍，可抑制人体脂肪的过量储存，抑制龋齿、促进钙的吸收。异麦芽酮糖醇甜度为蔗糖的45％～65％，不会导致龋齿，它和配方中的双歧杆菌具有协同作用，可促进双歧杆菌生长繁殖，改进中老年人群的肠道功能，维持微生态平衡。异麦芽酮糖醇和结晶果糖都不会引起体内血糖和胰岛素的升高，适合糖尿病人群和肥胖人群食用。
本发明的配方奶粉中还添加了特殊成分牛骨胶原蛋白肽。这种胶原蛋白易被人体吸收利用，可以增加皮肤弹性，防治骨质疏松和癌症，且矿物质丰富，可以调节身体内电解质平衡。
本发明的配方奶粉中选用吸收率较高的乳矿物盐作为钙质的来源，本配方中乳矿物盐的添加量约为8kg/吨粉，终产品中钙的强化量约为200mg/100g粉。乳矿物盐是天然活性高乳蛋白钙，具有科学的钙磷比2:1，易被人体吸收利用，吸收率大大高于其他普通钙，且对肠胃刺激小，不会导致肠胃不舒服，对中老年人群友好。
本发明的配方奶粉中硒的强化来源选用安琪酵母生物有限公司生产有机硒--富硒酵母，本配方中酵母硒的强化量约为20μg/100g。富硒酵母中的硒为纯生态硒，人体吸收率高，无毒副作用。
本发明的配方奶粉中添加的益生菌组合为动物双歧杆菌BB-115、鼠李糖乳杆菌MP108、长双歧杆菌婴儿亚种BLI-02，可抑制肠道内病原菌，调节肠道微生态。
本发明的配方奶粉中添加的植物甾醇酯可降低血液中胆固醇含量，预防心脑血管疾病；酵母β-葡聚糖和乳铁蛋白可增强机体免疫力，抑制肿瘤生长；磷脂酰丝氨酸可提高大脑机能，提高注意力，改善记忆力。
本申请一实施方式的一种益生菌富硒高钙中老年配方奶粉，添加了全面且真正适合中老年人群的健康状况和营养需求的营养物质，不仅可以很好地匹配中老年人群的健康需求，还可以起到保健调理的功效。
Claims (10)
1.一种益生菌富硒高钙中老年配方奶粉，其特征在于，包括如下质量份数比的成分：生牛乳干物质20.6～22.6份；脱脂乳粉29.2～30.8份；脱盐乳清粉19.2～20.8份；异麦芽酮糖醇10.0～11.0份；膳食纤维5.7～6.7份；结晶果糖占4.8～5.2份；植物油3.2～3.8份；牛骨胶原蛋白肽0.9～1.1份；乳矿物盐0.75～0.85份；植物甾醇酯0.37～0.43份；复配维生素0.245～0.255份；复配矿物质0.18～0.22份；酵母β-葡聚糖0.09～0.11份；蜂蜜粉0.09～0.11份；磷脂酰丝氨酸0.045～0.055份；富硒酵母0.009～0.011份；乳铁蛋白0.009～0.011份；益生菌组合0.009～0.011份。
2.根据权利要求1所述的益生菌富硒高钙中老年配方奶粉，其特征在于，所述膳食纤维包括低聚麦芽糖和菊粉。
3.根据权利要求2所述的益生菌富硒高钙中老年配方奶粉，其特征在于，所述膳食纤维中的各组分的质量份数比为：低聚麦芽糖76.4～77.4份、菊粉22.6～23.6份。
4.根据权利要求1所述的益生菌富硒高钙中老年配方奶粉，其特征在于，所述植物油包括大豆油和共轭亚油酸。
5.根据权利要求4所述的益生菌富硒高钙中老年配方奶粉，其特征在于，所述植物油中的各组分的质量份数比为：大豆油93.8～94.8份、共轭亚油酸5.2～6.2份，
其中所述共轭亚油酸包括顺-9，反-11-共轭亚油酸或反-9，顺-11-共轭亚油酸或反-9，反-11-共轭亚油酸或顺-9，顺-11-共轭亚油酸或反-10，顺-12-共轭亚油酸或顺-10，反-12-共轭亚油酸或顺-10，顺-12-共轭亚油酸或反-10，反-12-共轭亚油酸或顺-8，反-10-共轭亚油酸或反-8，顺-10-共轭亚油酸或顺-8，顺-10-共轭亚油酸或反-8，反-10-共轭亚油酸或反-11，顺-13-共轭亚油酸或顺-11，反-13-共轭亚油酸或顺-11，顺-13-共轭亚油酸或反-11，反-13-共轭亚油酸中的至少一种。
6.根据权利要求1所述的益生菌富硒高钙中老年配方奶粉，其特征在于，所述复配维生素包括维生素A醋酸视黄酯、胆钙化醇、dl-α-醋酸生育酚、盐酸吡哆醇、L-抗坏血酸、牛磺酸和乳糖。
7.根据权利要求6所述的益生菌富硒高钙中老年配方奶粉，其特征在于，所述复配维生素中的各组分的质量份数比为：维生素A醋酸视黄酯2.660～2.668份；胆钙化醇1.730～1.746份；dl-α-醋酸生育酚23.50～24.32份；盐酸吡哆醇0.0575～0.0590份；L-抗坏血酸36.60～36.84份；牛磺酸18.00～18.80份；乳糖15.90～16.10份。
8.根据权利要求1所述的益生菌富硒高钙中老年配方奶粉，其特征在于，所述复配矿物质包括硫酸亚铁、硫酸锌和乳糖。
9.根据权利要求8所述的益生菌富硒高钙中老年配方奶粉，其特征在于，所述复配矿物质中的各组分的质量份数比为：硫酸亚铁24.5～25.5份，硫酸锌7.90～8.90份，乳糖66.1～67.1份。
10.根据权利要求1所述的益生菌富硒高钙中老年配方奶粉，其特征在于，所述益生菌组合包括如下组分，按质量份数比：动物双歧杆菌BB-115 32.8～33.8份、鼠李糖乳杆菌MP108 32.8～33.8份、长双歧杆菌婴儿亚种BLI-02 32.8～33.8份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110954228.4A CN113693131A (zh) | 2021-08-19 | 2021-08-19 | 一种益生菌富硒高钙中老年配方奶粉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110954228.4A CN113693131A (zh) | 2021-08-19 | 2021-08-19 | 一种益生菌富硒高钙中老年配方奶粉 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113693131A true CN113693131A (zh) | 2021-11-26 |
Family
ID=78653449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110954228.4A Pending CN113693131A (zh) | 2021-08-19 | 2021-08-19 | 一种益生菌富硒高钙中老年配方奶粉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113693131A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023104181A1 (zh) * | 2021-12-10 | 2023-06-15 | 黑龙江飞鹤乳业有限公司 | 降血糖组合物 |
| WO2023237673A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237677A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237681A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237680A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111602720A (zh) * | 2020-05-11 | 2020-09-01 | 呼伦贝尔双娃乳业有限公司 | 一种中老年配方奶粉 |
-
2021
- 2021-08-19 CN CN202110954228.4A patent/CN113693131A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111602720A (zh) * | 2020-05-11 | 2020-09-01 | 呼伦贝尔双娃乳业有限公司 | 一种中老年配方奶粉 |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023104181A1 (zh) * | 2021-12-10 | 2023-06-15 | 黑龙江飞鹤乳业有限公司 | 降血糖组合物 |
| WO2023237673A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237677A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237681A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237680A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113693131A (zh) | 一种益生菌富硒高钙中老年配方奶粉 | |
| CN101248900B (zh) | 一种新型固体运动饮料冲剂 | |
| CN102511720B (zh) | 一种水苏糖婴幼儿营养米粉和其制备方法 | |
| CN109198356A (zh) | 一种具有调节肠道功能的固体饮料及其制备方法 | |
| CN111616232A (zh) | 一种促进骨骼生长的儿童奶粉及其制备方法 | |
| CN106135890A (zh) | 一种有助于骨关节健康的营养组合物 | |
| CN111602720A (zh) | 一种中老年配方奶粉 | |
| CN108244252A (zh) | 益生菌多元蛋白粉及其制备方法 | |
| CN110338402A (zh) | 一种复合益生菌粉及其制备方法 | |
| CN108272078A (zh) | 控制体重的特殊医学用途配方食品代餐粉及其制备方法 | |
| CN111771971A (zh) | 利于调节肠道、促进消化、改善便秘的组合物及其制备方法 | |
| CN111802550A (zh) | 一种益生菌配方饮料及其制备方法 | |
| CN103371318B (zh) | 一种膳食营养补充食品 | |
| CN104738638A (zh) | 具有抗疲劳作用的组合物及其用途 | |
| CN105076425A (zh) | 一种牦牛羊三合一复合婴幼儿配方奶粉 | |
| CN107889997A (zh) | 一种益生菌冻干粉固体饮料 | |
| CN114711374A (zh) | 酵纤复合营养素粉及其制备方法 | |
| CN107467193B (zh) | 一种以羊奶为基础的粉剂全营养特殊医学用途配方食品及其制备方法 | |
| CN105358127A (zh) | 促进减轻体重和/或保持体重的岩芹酸或至少包括岩芹酸的活性成分组合 | |
| CN113598231A (zh) | 一种添加复合膳食纤维、人源益生菌的无蔗糖酸奶及其制备方法 | |
| CN102273581A (zh) | 一种高甜度复配甜味剂 | |
| CN109303115A (zh) | 生酮减肥代餐奶昔 | |
| CN115590204A (zh) | 一种增强哺乳动物抗衰老的组合物 | |
| WO2021093880A1 (zh) | 产丁酸的益生元益生菌增效组合 | |
| CN110959797A (zh) | 一种益生元大豆蛋白肽固体饮料及其制备工艺 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |